Loading company…
Mirador Therapeutics develops precision therapies for immune-mediated diseases.
Mirador Therapeutics uses its Mirador360 platform to study patient molecular profiles, identify therapeutic targets, and develop diagnostics. The company was founded in 2023 and is based in California, US. It raised USD 333 million in series A funding in February 2024 and USD 250 million in series B funding in September 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in